| Literature DB >> 31586366 |
Rei Kobayashi1, Masato Ishizaki1.
Abstract
BACKGROUND: Online information seeking on medical topics by patients can have beneficial effects by helping them decide on treatment options and fostering better relationships with doctors. The quality of websites and processes of seeking information online have mostly been studied, with a focus on the accuracy and reliability of websites; however, few studies have examined the relationship between other aspects of quality and the processes of seeking medical information online.Entities:
Keywords: consumer health informatics; health communication; health literacy; information-seeking behavior; internet access
Year: 2019 PMID: 31586366 PMCID: PMC6783696 DOI: 10.2196/13240
Source DB: PubMed Journal: JMIR Cancer ISSN: 2369-1999
The websites visited by the participants (P1-P15), their staying time (in seconds), and their ratios (in brackets; calculated as the ratios of staying time for respective sites divided by that for all sites).
| Websites | P1a | P2 | P3 | P4 | P5 | P6 | P7 | P8 | P9 | P10 | P11 | P12 | P13 | P14 | P15 |
| PIb 1 | —c | 187.32 | 61.79 | 412.33 | 164.96 | — | 252.35 | — | 73.74 | — | 483.35 | 118.25 | 168.56 | — | — |
| PI 2 | 86.25 | — | — | — | — | — | — | — | 289.34 | 192.95 | — | 237.53 | 793.74 | — | 269.25 |
| PI 3 | — | 11.61 | — | — | — | — | — | — | 5.24 | — | — | 27.33 | — | 154.97 | 3.74 |
| PI 4 | — | 55.57 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| PI 5 | — | — | — | — | — | — | — | 115.92 | — | — | — | — | — | — | — |
| MId 1 | 87.25 | 36.38 | 151.64 | 104.58 | 451.58 | 232.66 | — | — | 73.67 | 56.93 | 21.97 | 22.66 | — | — | — |
| MI 2 | — | 78.84 | — | 16.92 | 423.89 | — | — | — | 24.51 | — | — | — | — | 66.05 | 105.51 |
| MI 3 | — | 211.45 | — | — | — | — | — | — | — | — | — | — | 36.38 | — | — |
| MI 4 | — | — | 133.27 | — | — | — | — | — | — | — | — | — | — | — | — |
| MI 5 | — | — | 290.27 | — | — | — | — | — | — | — | — | — | — | — | — |
| MI 6 | — | — | — | — | — | 337.91 | — | — | — | — | — | — | — | — | — |
| MI 7 | — | — | — | — | — | 188.34 | — | — | — | — | — | — | — | — | — |
| MI 8 | — | — | — | — | — | — | — | — | — | — | — | 261.49 | — | — | — |
| PCe 1 | — | 306.39 | 379.49 | 438.81 | 139.05 | 251.62 | 743.11 | 903.68 | 262.3 | 918.43 | 192.64 | 330.55 | 140.86 | 215.22 | 518.05 |
| PC 2 | — | 9.26 | 16.07 | 72.58 | — | — | — | — | — | — | — | 14.74 | — | — | 13.77 |
| PC 3 | — | — | — | — | — | — | 31.33 | – | 67.23 | — | 88.15 | — | — | 70.33 | — |
| PC 4 | — | — | — | — | — | — | — | — | — | — | 36.34 | — | — | – | — |
| CCf 1 | 346.48 | — | — | — | — | — | — | — | 164.78 | — | — | 93.05 | — | 127.42 | — |
| CC 2 | 2.33 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CC 3 | — | 18.09 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CC 4 | — | – | 22.63 | — | — | — | — | — | — | — | — | — | — | — | — |
| CC 5 | — | — | — | — | — | — | — | — | 25.19 | — | — | — | — | — | — |
| CC 6 | — | — | — | — | — | — | — | — | — | — | — | — | — | 541.93 | — |
| CC 7 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 9.49 |
| CC 8 | — | — | — | — | — | — | — | — | 107.29 | — | — | — | — | — | — |
| MPg | — | — | — | — | — | — | — | 48.12 | — | — | — | — | — | — | — |
| EDh 1 | 44.01 | — | — | — | — | — | 36.53 | — | — | — | — | — | — | — | — |
| ED 2 | — | 8.35 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ED 3 | — | — | — | 72.66 | — | — | — | — | — | — | — | — | — | — | — |
| Unknown | 61.24 | — | — | — | — | — | — | 92.88 | — | — | — | — | — | — | — |
aP: participant
bPI: nonprofit organizations and public institutions
cNot applicable.
dMI: medical institutions
ePC: pharmaceutical companies
fCC: commercial companies
gMP: medical professionals
hED: encyclopedias or dictionaries
The websites visited by the participants (P1-P15) and whether they included information about the disease and its treatment.
| Websites | Disease | Treatment options | |||||||||
|
| Non-small cell lung cancer | T-factor | T2a | N-factor | N1 | Stage | Stage ⅡB | Surgery | Chemotherapy followed by surgery | Radiation therapy for patients who cannot have surgery | |
| PIa 1 | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | |
| PI 2 | ✔ |
|
|
|
|
|
|
|
|
| |
| PI 3 |
|
| ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | |
| PI 4 |
|
|
|
|
|
|
|
|
|
| |
| PI 5 | ✔ | ✔ |
| ✔ |
| ✔ |
| ✔ | ✔ | ✔ | |
| MIb 1 | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
| ✔ | |
| MI 2 | ✔ |
|
|
|
| ✔ |
| ✔ | ✔ | ✔ | |
| MI 3 | ✔ |
| ✔ | ✔ | ✔ |
| ✔ | ✔ | ✔ | ✔ | |
| MI 4 | ✔ | ✔ | ✔ | ✔ |
|
|
| ✔ | ✔ |
| |
| MI 5 | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | |
| MI 6 | ✔ |
|
| ✔ |
|
| ✔ | ✔ | ✔ | ✔ | |
| MI 7 | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | |
| MI 8 | ✔ |
| ✔ | ✔ | ✔ |
| ✔ | ✔ |
| ✔ | |
| PCc 1 | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
| |
| PC 2 |
|
|
|
|
|
|
| ✔ | ✔ | ✔ | |
| PC 3 | ✔ |
|
|
|
| ✔ |
| ✔ | ✔ |
| |
| PC 4 | ✔ |
|
|
|
|
|
|
|
|
| |
| CCd 1 | ✔ |
|
|
|
|
|
| ✔ | ✔ | ✔ | |
| CC 2 |
|
|
|
|
| ✔ |
| ✔ |
|
| |
| CC 3 | ✔ |
|
|
|
|
|
|
|
|
| |
| CC 4 |
|
|
|
|
|
|
|
|
|
| |
| CC 5 |
|
|
|
|
|
|
|
|
|
| |
| CC 6 | ✔ |
|
| ✔ |
| ✔ |
| ✔ | ✔ | ✔ | |
| CC 7 | ✔ |
|
| ✔ | ✔ | ✔ |
| ✔ | ✔ |
| |
| CC 8 |
|
|
|
|
| ✔ |
|
|
|
| |
| MPd |
|
|
|
|
|
|
|
|
|
| |
| EDf 1 | ✔ |
| ✔ | ✔ |
| ✔ |
|
|
|
| |
| ED 2 | ✔ |
| ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
|
| |
| ED 3 | ✔ |
|
|
|
| ✔ |
| ✔ | ✔ |
| |
| Un-known |
| ✔ |
| ✔ | ✔ |
|
| ✔ | ✔ |
| |
aPI: nonprofit organizations and public institutions
bMI: medical institutions
cPC: pharmaceutical companies
dCC: commercial companies
eMP: medical professionals
fED: encyclopedias or dictionaries